# Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag

> **NCT00888901** · PHASE4 · COMPLETED · sponsor: **Ingrid Pabinger, MD** · enrollment: 30 (actual)

## Conditions studied

- Idiopathic Thrombocytopenic Purpura

## Interventions

- **DRUG:** eltrombopag
- **DRUG:** corticosteroids (Aprednislon)

## Key facts

- **NCT ID:** NCT00888901
- **Lead sponsor:** Ingrid Pabinger, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-03
- **Final completion:** 2011-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00888901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00888901, "Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00888901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*